Koito Manufacturing Co., Ltd. – Acquisition of Cepton, Inc.
Nishimura & Asahi advised Koito Manufacturing, Co., Ltd. [TSE: 7276] on its acquisition of Cepton, Inc. [NSQ:CPTN], a leading provider of lidar-based solutions for automotive.
The Nishimura & Asahi team advising Koito Manufacturing was led by partners Tatsuya Tanigawa, Yasunori Ishizaki, Yusuke Urano and Alisa Inuzuka.
People
Since joining Nishimura & Asahi in 2006, Yasunori has dealt with various M&A transactions in Japan and overseas. In particular, with respect to transactions involving listed companies, he excels at strategizing flexibly based on the complex circumstances and needs of the parties concerned, and seeing such projects to completion. When handling M&A transactions, he places an emphasis on maximizing the benefit to his clients while giving due consideration to the overall benefit to all of those involved. In addition to the above, Yasunori has advised on defenses against hostile takeovers and responses to shareholder activism for companies such as Toshiba Machine (currently Shibaura Machine) and Tokyo Kikai Seisakusho. In recent years, he has also provided advice for the acquisition side of hostile takeovers, with industrial companies as his clients.
Based in New York, Yusuke has advised on numerous M&A transactions, such as domestic/cross-border acquisitions and alliances, TOB transactions, going private/MBO transactions, joint venture transactions, venture capital investments, and group reorganizations, with a focus on Japan-U.S. cross-border M&A transactions. He has also handled various cross border cartel cases for domestic and foreign clients. He also regularly provides U.S. and global clients doing business in Japan with corporate governance, compliance, risk management, labor, intellectual property, and other general corporate advice.
Alisa Inuzuka advises clients in the life science and healthcare industries on matters including pharmaceuticals, medical devices, in vitro diagnostics, cosmetics, health foods, medical systems, and laboratory tests. In addition, she has experience in M&A, regulatory advice, reviewing and drafting various contracts, and crisis management and investigation, as well as communicating with the relevant authorities in these areas. She also supports non-healthcare companies in entering into the healthcare industry as well as the entry of non-Japanese healthcare companies into the Japanese market. She seeks to contribute to enhancing people’s health and lives by working to maximize clients’ business opportunities.
Tatsuya Tanigawa is a partner at Nishimura & Asahi, and has represented Japanese and non-Japanese buyers and sellers in numerous cross-border transactions in various industries, including stock and asset acquisitions, private equity and venture capital investments, joint ventures, and strategic alliances. He has handled both inbound and outbound transactions, including many public company transactions. He is committed to finding solutions for his clients in any transaction.